Page last updated: 2024-11-13

imidazole-1-sulfonyl azide hydrochloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

imidazole-1-sulfonyl azide: a diazotransfer reagent.; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23583982
SCHEMBL ID515372
MeSH IDM0514979

Synonyms (22)

Synonym
FT-0696128
XYURSCOGYWBRDR-UHFFFAOYSA-N
952234-36-5
AKOS016015616
imidazole-1-sulfonyl azide
imidazole-1-sulfonyl azide hydrochloride ,
1h-imidazole-1-sulfonyl azide hydrochloride
SCHEMBL515372
F2147-2502
n-diazoimidazole-1-sulfonamide;hydrochloride
BS-13556
imidazole-1-sulfonylazide hydrochloride
Q6003986
1h-imidazole-1-sulfonyl azide hcl
BCP14462
AMY23780
EN300-112206
n-diazoimidazole-1-sulfonamide hydrochloride
A854679
EX-A3821
1h-imidazole-1-sulphonyl azide hydrochloride
SY006102
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's8 (88.89)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.05 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.53 (4.65)
Search Engine Demand Index36.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]